MIRM
NASDAQ
$116.62
Mirum Pharmaceuticals Inc (MIRM)
Mirum Pharmaceuticals, Inc., a biopharmaceutical company, is focused on the development and commercialization of an advanced line of novel therapies for debilitating liver diseases. The company is headquartered in Foster City, California.
Sector:
Healthcare
Industry:
Biotechnology
Strong Buy
Target: $146.50 (+25.62%)
Market Cap
$7.37B
Free Cash Flow Yield
-2.34%
Beta (5Y)
0.84
Price Chart
Valuation
Market Cap$7.37B
Forward P/E2000.00
P/S12.95
P/B30.40
Profitability
Total Revenue (TTM)$521M
Gross Profit (TTM)$464M
EBITDA$2.11M
Profit Margin-3.8%
Operating Margin-3.1%
EPS-$0.47
Financial Health
Free Cash Flow Yield-2.34%
Growth & Risk
EPS 5Y CAGR-34.51%
FCF 5Y CAGR+12.43%
Beta (5Y)0.84
Sharpe Ratio1.89